Prospects for assessing the biological and immunological age of a person by blood factors

According to the WHO, by 2050 in developed countries, the population over 60 years old will double. This will lead to a further increase in the retirement age and an elevation of burden on the health care system. Therefore, there is an acute issue of maintaining health and prolonging active longevity, as well as the introduction of monitoring for prevention of premature aging and age-related disorders to avoid early disability. The review aims to discuss the aging process and identify critical blood factors affecting or indicating progress in biological aging. The connection of biological age, the regenerative and immune systems aging with the shift in circulating blood factors have been evaluated. The concepts of "health and longevity hygiene" and the concept of "immunological age" are debated. Perspective methods of rapid and multiplex analyzes of blood factors are discussed, as well as the prospects for preliminary analysis of biological and immunological age at home with subsequent processing in high-tech centers to identify risk groups and monitor healthy aging. Approaches to protecting health, slowing aging and rejuvenating the elderly, maintaining healthy aging, and prolonging active life have been defined

The groups of patients by genetic research for sensibility to Dalcetrapib therapy

The article deals with the search for phenotypic differences between patients with genotypically determined susceptibility to the drug Dalcetrapib and without it.В статье рассмотрены вопросы поиска фенотипических отличий между пациентами с генотипически обусловленной восприимчивостью к препарату Далцетрапиб и без нее